Long gone are the days when the tobacco industry could try to entice Australians to smoke particular brands with sophisticated, well-researched package design, but many countries around the... Read more
Gummy vitamins that are being marketed to children are unhealthy and exploitative products, and their regulation should be reviewed. That is the call for action from the authors of the artic... Read more
Drugs deemed safe and suitable for human use by other jurisdictions could be fast-tracked for approval in Australia under proposed government reforms aimed at reducing red tape and regulatio... Read more
The Pharmaceutical Benefits Advisory Committee and the Therapeutic Goods Administration have been urged to clarify their policies around “biosimilars” – drugs which act in the same way as pa... Read more
The failure of some medical devices in recent years, such as the PIP breast implants and metal-on-metal hip prostheses, have raised questions about the safety of medical technologies more ge... Read more
Note: A response from the TGA was added on 28 March – see bottom of post. Questions are again being raised about the effectiveness of the Therapeutic Goods Administration as a regulato... Read more
Michelle Culhane-Hughes writes: Last week JAMA Dermatology published an interesting study into the accuracy of smart phone applications in diagnosing melanoma: Diagnostic Inaccuracy of Smart... Read more
The decision to delay further the introduction of subsidies for the anti-stroke drug, Pradaxa, puts Australia at odds with the rest of the developed world. It also raises ques... Read more
Below is an article that ran earlier this week in the Crikey bulletin raising concerns about the ongoing availability of two pain management medicines, and the processes that have enabled th... Read more
The Therapeutic Goods Administration’s response to concerns about the marketing of a weight-loss pill, which lets you “have the cake without the calories”, suggests that the many revie... Read more
